Intelligent Pharmaceutical Composition Development and Monitoring System

A comprehensive system integrating machine learning, blockchain, IoT, and 3D printing technologies to optimize pharmaceutical composition development, monitoring, and production, ensuring enhanced stability, authenticity, and personalized treatment.

The original patent disclosed a pharmaceutical composition comprising an antibody, glycine, acetate buffer, and polysorbate 80. However, the development and production of such compositions often face challenges related to stability, authenticity, and personalization. The new inventive concept addresses these limitations by introducing a synergistic combination of advanced technologies to create a more powerful system.

The system comprises a database storing data on pharmaceutical compositions, an AI model trained on the database to predict optimal composition parameters, and a prediction module for determining the optimal composition. Additionally, the system integrates blockchain technology to track composition development and verify authenticity. IoT sensors monitor storage conditions, and a notification module alerts users of deviations from optimal storage conditions. The system also utilizes 3D printing to create personalized pharmaceutical compositions based on patient data. Furthermore, an artificial neural network is employed to predict composition stability.

The new inventive concept introduces a novel combination of machine learning, blockchain, IoT, and 3D printing technologies to optimize pharmaceutical composition development, monitoring, and production. The integration of these distinct technologies provides an inventive step beyond the original patent, enabling enhanced stability, authenticity, and personalized treatment.

Alternative embodiments may include using different AI models or machine learning algorithms, integrating additional technologies such as robotics or virtual reality, or applying the system to other fields beyond pharmaceutical compositions. Variations may include adapting the system for specific disease treatments or developing mobile applications for patient monitoring.

The Intelligent Pharmaceutical Composition Development and Monitoring System has significant commercial potential in the pharmaceutical industry, particularly in the development of personalized medicines and biologics. The system's ability to ensure composition stability, authenticity, and personalized treatment can lead to improved patient outcomes, reduced costs, and increased market share.